Dr. Vinod Kumar Valiveti, MD

Dr. Valiveti practices at Vinod K. Valiveti M.D. Inc. in Camarillo, California.

Dr. Valiveti's NPI, 1598714107, was assigned on May 9, 2006. Dr. Valiveti graduated from Guntur Medical College NTR in 1993. Dr. Valiveti holds California license A73845.

Dr. Valiveti's primary practice is Vinod K. Valiveti M.D. Inc., at 1567 Flynn Rd, Camarillo, CA 93012 in Ventura County. The practice phone is (805) 278-0720.

Dr. Valiveti's primary practice is Vinod K. Valiveti M.D. Inc. in Camarillo, California. The medical group on file is Pacific Inpatient Physicians. Dmand AI also links Dr. Valiveti to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valiveti practices. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Valiveti's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dmand AI has Dr. Valiveti's licenses on file in 3 states: California, Massachusetts and New York.

Dmand AI lists acid reflux, aneurysm, asthma, atrial fibrillation and flutter, benign or precancerous skin growths, bladder disease, cardiomyopathy and cerebrovascular disease among the conditions Dr. Valiveti treats.

CMS data shows 2,503 Medicare services from Dr. Valiveti across 4 procedure codes in 2024, for 577 Medicare patients. Medicare paid $233,071 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 577 Medicare patients who saw Dr. Valiveti in 2024. The largest group is 85 and over, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valiveti's median patient age at 81, with 59% women.

In 2024, Dr. Valiveti wrote 15,327 Medicare Part D claims for 561 patients. 85% of them were for generic drugs. CMS names the drug for 14,678 of them, across 207 drugs with 11 or more claims each, at $792,502 in total drug cost. In 2023, CMS named 12,871 claims across 200 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Valiveti for performance year 2024, reported individually.

CMS Open Payments shows 47 general payments to Dr. Valiveti from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $349.

Dr. Valiveti graduated from Guntur Medical College NTR in 1993.

Dr. Valiveti is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Regence Health Plans. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.